An innovative hair growth solution

Therapy-07

Prescription

This innovative triple combination therapy promotes hair regrowth in men with androgenic alopecia. Its exclusive combination of molecules acts at various stages of the hair growth cycle to stop hair loss and stimulate regrowth, while also making hair thicker and darker. The effectiveness of this revolutionary solution was proven in the first two phases of clinical trials, where participants all observed positive results that ranged from moderate to exceptional.

PHASE III CLINICAL TRIALS 2022

Product highlights

Therapy-07

 

Maximum regrowth
formula for men only

 

Single daily
topical application

 

Triple combination
synergy

Product
milestones

Phase III clinical trials will be initiated in 2022
Pharmacy distribution
Partners
network

Target distribution channels

Although we ultimately want to launch our product globally, these would be our initial distribution channels for Therapy-07.

Subscribe to our waiting list

We are working hard to get the product to market as soon as possible. Sign up for the waiting list to be notified when it will be available in your country.